Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Dollery C. T., Rawlins M. D. Monitoring adverse reactions to drugs. Br Med J. 1977 Jan 8;1(6053):96–97. doi: 10.1136/bmj.1.6053.96. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Harron D. W., Griffiths K., Shanks R. G. Debendox and congenital malformations in Northern Ireland. Br Med J. 1980 Nov 22;281(6252):1379–1381. doi: 10.1136/bmj.281.6252.1379. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Moir D. C., Alexander E. R., Barnett J. W., Christopher L. J. A hospital based drug information system. Health Bull (Edinb) 1975 Mar;33(2):82–88. [PubMed] [Google Scholar]
- Royall B. W. International aspects of drug monitoring. Role of the World Health Organization. WHO Chron. 1971 Oct;25(10):445–451. [PubMed] [Google Scholar]
- Skegg D. C., Doll R. Frequency of eye complaints and rashes among patients receiving practolol and propranolol. Lancet. 1977 Sep 3;2(8036):475–478. doi: 10.1016/s0140-6736(77)91602-6. [DOI] [PubMed] [Google Scholar]
- Slone D., Jick H., Borda I., Chalmers T. C., Feinleib M., Muench H., Lipworth L., Bellotti C., Gilman B. Drug surveillance utilizing nurse monitors. An epidemiological approach. Lancet. 1966 Oct 22;2(7469):901–903. doi: 10.1016/s0140-6736(66)91997-0. [DOI] [PubMed] [Google Scholar]
- Wright P. Untoward effects associated with practolol administration: oculomucocutaneous syndrome. Br Med J. 1975 Mar 15;1(5958):595–598. doi: 10.1136/bmj.1.5958.595. [DOI] [PMC free article] [PubMed] [Google Scholar]